Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MoonLake Immunotherapeutics | 10%+ Owner | Class A Ordinary Shares | 8.49M | $509M | $59.90 | Oct 5, 2023 | Indirect |
Erasca, Inc. | Director | Common Stock | 10.8M | $17.2M | $1.59 | Jun 22, 2023 | Indirect |
Biomea Fusion, Inc. | Director, 10%+ Owner | Common Stock | 3.57M | $15.8M | $4.43 | Jun 12, 2024 | Indirect |
Helix Acquisition Corp. II | CEO and Chairperson, Director, 10%+ Owner | Class A Ordinary Shares | 904K | Feb 13, 2024 | Indirect | ||
Erasca, Inc. | Director | Stock Option (right to buy) | 60K | Jun 22, 2023 | Direct | ||
Biomea Fusion, Inc. | Director, 10%+ Owner | Stock Option (right to buy) | 51 | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BMEA | Biomea Fusion, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 13, 2024 | Director, 10%+ Owner |
HLXB | Helix Acquisition Corp. II | Feb 13, 2024 | 4 | $29.1M | 4 | Feb 13, 2024 | CEO and Chairperson, Director, 10%+ Owner |
HLXB | Helix Acquisition Corp. II | Feb 8, 2024 | 0 | $0 | 3 | Feb 9, 2024 | CEO and Chairperson, Director, 10%+ Owner |
MLTX | MoonLake Immunotherapeutics | Oct 5, 2023 | 1 | $3.52M | 4 | Oct 10, 2023 | 10%+ Owner |
MLTX | MoonLake Immunotherapeutics | Oct 2, 2023 | 3 | $16.8M | 4 | Oct 4, 2023 | 10%+ Owner |
MLTX | MoonLake Immunotherapeutics | Jun 30, 2023 | 1 | $40M | 4 | Jul 5, 2023 | 10%+ Owner |
MLTX | MoonLake Immunotherapeutics | Jun 26, 2023 | 27 | $20.5M | 4 | Jun 28, 2023 | 10%+ Owner |
ERAS | Erasca, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
BMEA | Biomea Fusion, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director, 10%+ Owner |
BMEA | Biomea Fusion, Inc. | Mar 30, 2023 | 1 | $12M | 4 | Apr 3, 2023 | Director, 10%+ Owner |
MLTX | MoonLake Immunotherapeutics | Mar 20, 2023 | 4 | $16.8M | 4 | Mar 22, 2023 | 10%+ Owner |
ERAS | Erasca, Inc. | Dec 20, 2022 | 1 | $2M | 4 | Dec 20, 2022 | Director |
ERAS | Erasca, Inc. | Dec 13, 2022 | 1 | $2M | 4/A | Dec 21, 2022 | Director |
ERAS | Erasca, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
BMEA | Biomea Fusion, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director, 10%+ Owner |
MLTX | MoonLake Immunotherapeutics | Apr 5, 2022 | 3 | $28.5M | 4 | Apr 7, 2022 | 10%+ Owner |
ERAS | Erasca, Inc. | Jul 26, 2021 | 2 | $667K | 4 | Aug 10, 2021 | Director |
ERAS | Erasca, Inc. | Jul 20, 2021 | 5 | $15.2M | 4 | Jul 22, 2021 | Director |
ERAS | Erasca, Inc. | Jul 15, 2021 | 0 | $0 | 3/A | Jul 16, 2021 | Director, 10%+ Owner |